Fig. 5: LMW-E and CDK5 are associated with recurrence-free survival in all subtypes of salivary gland tumors. | Oncogenesis

Fig. 5: LMW-E and CDK5 are associated with recurrence-free survival in all subtypes of salivary gland tumors.

From: LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers

Fig. 5: LMW-E and CDK5 are associated with recurrence-free survival in all subtypes of salivary gland tumors.

Forest plots analysis indicating univariable analysis of the indicated variables with recurrence-free survival in each subtype. The solid gray line indicates a hazard ratio of 1 for the overall population. Variables with p values <0.05 are marked with * and are significant predictors of recurrence-free survival for each subtype, calculated using the Cox proportional-hazards model.

Back to article page